Literature DB >> 28660220

F-18 FDG PET/CT Imaging of Eccrine Sweat Gland Carcinoma of the Scrotum with Extensive Regional and Distant Metastases.

Jin-Suk Kim1.   

Abstract

Eccrine carcinoma is an extremely rare malignant skin cancer arising from eccrine sweat glands with a high metastatic potential. It mainly occurs in the elderly, with equal incidence in both sexes. It usually spreads to regional lymph nodes, with liver, lungs, and bones being the most common sites of distant metastasis. Because of tumor rarity, little is known about the value of F-18 FDG PET/CT in evaluating this disease. Our case report aims to increase current knowledge of F-18 FDG PET/CT in eccrine sweat gland carcinoma as a noninvasive imaging tool for assessing the extension of the disease and detecting distant metastases. We reported a 96-year-old man who presented with as lowly progressive, ill-margined erythematous papules and nodules with a crusted and eroded involving multiple sites of groin, scrotum, penis, left pelvic wall, left hip and left thigh for >3 years, which became extensive in the past 2 months. The histologic investigation confirmed the diagnosis of an eccrine carcinoma. He was performed F-18 FDG PET/CT to further evaluate the lesions. FDG PET/CT imaging revealed FDG uptake at the extensive skin lesion, involvement of lymph nodes, and multiple FDG-avid of liver, skeletal and lung metastases.

Entities:  

Keywords:  Distant metastasis; Eccrine sweat gland carcinoma; F-18 FDG; PET/CT; Scrotum

Year:  2017        PMID: 28660220      PMCID: PMC5482914          DOI: 10.22038/aojnmb.2017.19550.1145

Source DB:  PubMed          Journal:  Asia Ocean J Nucl Med Biol        ISSN: 2322-5718


  15 in total

1.  Sweat gland carcinoma with multiple local recurrences: a case report.

Authors:  D Panoussopoulos; A Darom; A C Lazaris; P Misthos; K Papadimitriou; G Androulakis
Journal:  Adv Clin Path       Date:  1999-07

2.  Sweat gland carcinoma: a clinico-pathological reappraisal.

Authors:  D L Mitts; M T Smith; L Russell; G A Bannayan; A B Cruz
Journal:  J Surg Oncol       Date:  1976       Impact factor: 3.454

3.  Increased FDG uptake along dermatome on PET in a patient with herpes zoster.

Authors:  Charles Egan; Eugene Silverman
Journal:  Clin Nucl Med       Date:  2013-09       Impact factor: 7.794

Review 4.  Malignant skin and subcutaneous neoplasms in adults: multimodality imaging with CT, MRI, and 18F-FDG PET/CT.

Authors:  Yu-Hsiang Juan; Sachin S Saboo; Sree Harsha Tirumani; Ashish Khandelwal; Atul B Shinagare; Nikhil Ramaiya; Katherine M Krajewski
Journal:  AJR Am J Roentgenol       Date:  2014-05       Impact factor: 3.959

Review 5.  De novo malignant eccrine spiradenoma with an interesting and unusual location.

Authors:  S Yildirim; T Aköz; M Akan; G A Ege
Journal:  Dermatol Surg       Date:  2001-04       Impact factor: 3.398

Review 6.  Microcystic adnexal carcinoma: report of 13 cases and review of the literature.

Authors:  S Snow; D D Madjar; S Hardy; M Bentz; M J Lucarelli; R Bechard; W Aughenbaugh; T McFadden; H Sharata; C Dudley; A Landeck
Journal:  Dermatol Surg       Date:  2001-04       Impact factor: 3.398

7.  Carcinomas of sweat glands: report of 60 cases.

Authors:  C Urso; R Bondi; M Paglierani; A Salvadori; C Anichini; A Giannini
Journal:  Arch Pathol Lab Med       Date:  2001-04       Impact factor: 5.534

8.  Surgical resection for pulmonary metastases of sweat gland carcinoma.

Authors:  T Osaki; M Kodate; R Nakanishi; T Mitsudomi; T Shirakusa
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

9.  Cutaneous and subcutaneous imaging on FDG-PET: benign and malignant findings.

Authors:  Steven L Blumer; Luke R Scalcione; Bobbi N Ring; Ravi Johnson; Betty Motroni; Douglas S Katz; Elizabeth Y Yung
Journal:  Clin Nucl Med       Date:  2009-10       Impact factor: 7.794

10.  Clinical management of a case of recurrent apocrine gland carcinoma of the scalp: efficacy of a chemotherapy schedule with methotrexate and bleomycin.

Authors:  A Morabito; P Bevilacqua; S Vitale; M Fanelli; D Gattuso; G Gasparini
Journal:  Tumori       Date:  2000 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.